On the other hand, insulin conjugated to GLUT inhibitors has been employed for drug depots, half-life extension, and drug release, a strategy to mitigate the insulin-induced hypoglycemia in type 1 diabetic mouse model15. This evidence concerns the gene SLC2A1 and Hypoglycemia.